Annotation Detail for KCNS3
Basic Information
TopGene Symbol: | KCNS3 ( KV9.3,MGC9481 ) |
---|
Gene Full Name: | potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
---|
Band: | 2p24.2 |
---|
Quick Links | Entrez ID:3790; OMIM: 603888; Uniprot ID:KCNS3_HUMAN; ENSEMBL ID: ENSG00000170745; HGNC ID: 6302 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
| Diabetes pathways |
| Integration of energy metabolism |
Desease Name |
---|
airway hyperresponsiveness |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KCNS3 mRNA | affects expression | 16483693
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of KCNS3 mRNA | increases expression | 16002434
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of KCNS3 mRNA | decreases expression | 19559774
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of KCNS3 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.35 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.19 | 18287403 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.96 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.90 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 18396377 17507914 18940202 20603192 19232924 18316065 16609825 15238991 18177632 18985861 17688650 18558336 18775368 17157402 19460635 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.24 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.63 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.56 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.71 | 11237771 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
4.20 | 19559774 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.82 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.91 | 16575769 17688650 8888407 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.51 | 1851702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.44 | 15138306 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.71 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.64 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.11 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.96 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.86 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.69 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.72 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.61 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.64 | 18558336 8888407 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.20 | 17596541 16294345 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.98 | 17228818 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.47 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.45 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.35 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.37 | 16359493 8888407 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.46 | 20603192 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.41 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.48 | 15754350 16644109 18247401 16289102 12479363 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.26 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.64 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.99 | 11044598 16876388 3137016 15475178 14763951 11738929 1511512 17978042 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.09 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.26 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.96 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.15 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.20 | 8888407 |